Skip to content
DraconiticResearch
Search Sources API
203,952 studies31 sourcesUpdated 19 min ago

Oncology

5,176 studies502 in 7 days2,477 in 30 days

Filters
Type
Date
Clear

Latest

5,176 studies

  1. A Real-world Study on the Prognosis of Patients with Pancreatic Cancer: A Prospective Stationary Survey from 2007-2020
    Akinori Abe, Hiroshi Ohyama, Yoshiki Asahina +16
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textOncologyJ-STAGE
  2. Risk Factors for Pneumonitis in Patients with Unresectable Advanced Non-small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors
    Taisuke Isono, Akihiro Ishida, Yoko Onodera +8
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textOncologyJ-STAGE
  3. Dysregulation of selected lncRNAs and Hippo/EMT-associated genes in hepatocellular carcinoma patients.
    Ana Maria Ciurdorean, Paul Chiroi, Liviuta Budisan +9
    Medicine and pharmacy reportsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  4. Investigation of selected MiRNA as potential biomarker in chronic myeloid leukemia patients.
    Moath Alqaraleh, Jehad F Alhmoud, Issa I Dababneh +4
    Medicine and pharmacy reportsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  5. Local ablative treatment for oligoprogression during immunotherapy in metastatic non-small-cell lung cancer: a systematic review and meta-analysis
    Ismaell Massalha, Adham Hijab, Reem Zabit +3
    OncoimmunologyPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  6. Spiral Jejunal Reconstruction of Both Pancreatic Stumps in Type II Portal Annular Pancreas during Pancreaticoduodenectomy: A Case Report
    Hiroto Suzuki, Ken Ishikawa, Takuya Bamba +5
    Surgical Case ReportsPeer-reviewedCC BY 4.0Full textOncologyPMC
  7. High LAT1 Expression Is Associated With CD163⁺ Macrophage Infiltration and Poor Prognosis in Triple-Negative Breast Cancer
    YUN-SHAN LIN, SHU-FEN CHIANG, TSUNG-WEI CHEN +5
    Cancer Genomics & ProteomicsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  8. Prognostic scores and biomarkers in hematologic malignancies: current evidence and future perspectives
    Eliot McDonald, Emanuela Marcenaro, Philippe Robert +3
    Biomarker ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  9. MAGI3 Acts as an Intestinal Epithelial Gatekeeper in Inflammation‐Associated Colorectal Cancer by Suppressing the STAT3‐CCL2 Axis and TAM‐Mediated Immunosuppression
    Yumeng Yang, Zhigang Bai, Haibo Wang +10
    Advanced SciencePeer-reviewedCC BY 4.0Full textOncologyPMC
  10. Managing trastuzumab deruxtecan-related adverse events in patients with metastatic breast cancer: insights from a worldwide survey of the Hermione EDUcational project
    Marina Elena Cazzaniga, Matti Aapro, Manuel Alva Bianchi +18
    Supportive Care in CancerPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  11. Dual targeting of ACSS2 and ACLY by a novel inhibitor S8588 suppresses oncogenic lipogenesis and overcomes metabolic compensation in oral squamous cell carcinoma
    Tiao Luo, Zhengnan Ming, Haixia Zhang +11
    International Journal of Oral SciencePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  12. Coping strategies in patients with brain neoplasms: clinical psychological differences and adaptive potential
    Kamilla Kholmuradova, Alexandra Maslennikova
    Journal of Neuro-OncologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  13. Operative efficiency and short-term outcomes of da Vinci 5 versus da Vinci Xi in robotic rectal cancer surgery: an overlap-weighted cohort study with an exploratory case insights analysis
    Yasuhiro Ishiyama, Yasumitsu Hirano, Yurie Kitano +10
    Journal of Robotic SurgeryPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  14. Addressing Power of Equivalence Tests for Statistical Fairness Assessments of Machine Learning Models in Healthcare
    David Watson, Momin M. Malik, Jennifer Le-Rademacher +4
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  15. Microenvironmental IL13 Rα2 Expression and Enable Extracellular Vesicle-Mediated Antigen Transfer in Glioblastoma
    Yujun Wang, Ryan Urak, Clara Chen +3
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  16. A 20-Year Real-World Benchmark of Metastatic Uveal Melanoma Outcomes in a Tebentafusp-Inaccessible Setting: A Comprehensive Cancer Center Study
    Yacob Saleh, Baker Shiha, Manar Abu Awwad +11
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  17. ACP3 Theranostics in Prostate Cancer
    Zhilin Luo, Danlei Chen, Tianyi Ma +4
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  18. Kidney Injury in Adults After Hematopoietic Stem Cell Transplantation: Acute Kidney Injury, Transplant-Related Complications, and Long-Term Outcomes
    Lamis Almalki, Nina Weber, Anup Devasia +1
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  19. Circulating microRNAs Capture Inflammatory and Muscle Wasting Phenotypes in Patients with Gastrointestinal Cancer
    Federica Tambaro, Simona Orlando, Giovanni Imbimbo +6
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  20. Comparison of Survival Outcomes with First-Line PARP Inhibitor Maintenance According to BRCA Mutation and Homologous Recombination Deficiency Status in Advanced Ovarian Cancer: A Single-Center Retrospective Cohort Study
    Young Joo Choi, Jung-Yun Lee, Eun Ji Nam +3
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  21. Representation of Surgery in Registered Clinical Trials for Brain Metastases: An Analysis of the ClinicalTrials.gov Database
    Sandra Leskinen, Nathan A. Shlobin, Roland A. Scott +3
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  22. ORTHOTOPIC TUMOUR INDUCTION PROTOCOL SHAPES TUMOUR MICROENVIRONMENT
    S. McClelland, Y. Liu, G. Allocca +3
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  23. Single-cell characterization of 3D CLL spheroid model that recapitulates lymph node microenvironment-driven phenotypes and in vivo drug responses to ibrutinib
    M. V. Haselager, D. Lashgari, A. Jongejan +7
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  24. Strategies of mechanical adaptations of circulating tumor cells and properties of their cellular microenvironment have predictive and prognostic biomarker value
    M. Gaczynska, F. Ataei, C.-W. Chou +10
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  25. Revamped transposon-induced hepatocellular carcinoma model reveals deep similarities of cancer-driver landscapes across mice and humans
    G. Imre, A. Mates-Nagy, M. Raya +15
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv